The role of metastasectomy in renal cell carcinoma.
Despite significant advances in the systemic treatment of metastatic renal cell carcinoma, long-term survival remains low. A potential way to improve outcomes in selected cases is the use of metastasectomy, which is part of the multimodal treatment of this disease. Although the evidence supporting this approach is limited, we believe it is a reasonable option for certain patients. This review summarizes the evidence supporting this approach.
Department of Medical Oncology, Guy's Hospital, London, SE1 9RT, UK.
Eleni
E
Josephides
Alejo
A
Rodriguez-Vida
Myria
M
Galazi
Simon
S
Chowdhury
Aneta
A
Suder
D000310:Adrenal Gland Neoplasms / Q000556:secondary / Q000601:surgery; D001859:Bone Neoplasms / Q000556:secondary / Q000601:surgery; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology / Q000601:surgery*; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D008175:Lung Neoplasms / Q000556:secondary / Q000601:surgery; D059146:Metastasectomy; D010190:Pancreatic Neoplasms / Q000556:secondary / Q000601:surgery; D016896:Treatment Outcome